CA2658559A1 - Induction de reponses immunes cellulaires au virus de la grippe grace a des compositions de peptides et d'acides nucleiques - Google Patents

Info

Publication number

CA2658559A1

CA2658559A1 CA002658559A CA2658559A CA2658559A1 CA 2658559 A1 CA2658559 A1 CA 2658559A1 CA 002658559 A CA002658559 A CA 002658559A CA 2658559 A CA2658559 A CA 2658559A CA 2658559 A1 CA2658559 A1 CA 2658559A1

Authority

CA

Canada

Prior art keywords

epitope

polynucleotide

hla

epitopes

htl

Prior art date

2006-07-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 241000712461 unidentified influenza virus Species 0.000 title claims abstract description 168
• 108090000765 processed proteins & peptides Proteins 0.000 title claims description 565
• 102000039446 nucleic acids Human genes 0.000 title claims description 164
• 108020004707 nucleic acids Proteins 0.000 title claims description 164
• 150000007523 nucleic acids Chemical class 0.000 title claims description 153
• 239000000203 mixture Substances 0.000 title claims description 128
• 230000001939 inductive effect Effects 0.000 title claims description 13
• 230000024932 T cell mediated immunity Effects 0.000 title description 7
• 238000000034 method Methods 0.000 claims abstract description 97
• 108091007433 antigens Proteins 0.000 claims abstract description 75
• 102000036639 antigens Human genes 0.000 claims abstract description 75
• 239000000427 antigen Substances 0.000 claims abstract description 73
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 416
• 229920001184 polypeptide Polymers 0.000 claims description 204
• 102000040430 polynucleotide Human genes 0.000 claims description 172
• 108091033319 polynucleotide Proteins 0.000 claims description 172
• 239000002157 polynucleotide Substances 0.000 claims description 172
• 210000002443 helper t lymphocyte Anatomy 0.000 claims description 169
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 164
• 206010022000 influenza Diseases 0.000 claims description 161
• 241000282414 Homo sapiens Species 0.000 claims description 144
• 150000001413 amino acids Chemical class 0.000 claims description 119
• 108090000623 proteins and genes Proteins 0.000 claims description 114
• 210000004027 cell Anatomy 0.000 claims description 110
• 229940024606 amino acid Drugs 0.000 claims description 105
• 235000001014 amino acid Nutrition 0.000 claims description 105
• 102000004169 proteins and genes Human genes 0.000 claims description 83
• 235000018102 proteins Nutrition 0.000 claims description 79
• 230000028993 immune response Effects 0.000 claims description 70
• 101710154606 Hemagglutinin Proteins 0.000 claims description 64
• 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 64
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 64
• 101710176177 Protein A56 Proteins 0.000 claims description 64
• 239000000185 hemagglutinin Substances 0.000 claims description 59
• 230000008685 targeting Effects 0.000 claims description 59
• 102000005348 Neuraminidase Human genes 0.000 claims description 49
• 108010006232 Neuraminidase Proteins 0.000 claims description 49
• 239000013604 expression vector Substances 0.000 claims description 45
• -1 spacer nucleic acids Chemical class 0.000 claims description 45
• 108091054438 MHC class II family Proteins 0.000 claims description 39
• 102000043131 MHC class II family Human genes 0.000 claims description 33
• 239000013598 vector Substances 0.000 claims description 33
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 32
• 238000012545 processing Methods 0.000 claims description 32
• 108010074032 HLA-A2 Antigen Proteins 0.000 claims description 25
• 102000025850 HLA-A2 Antigen Human genes 0.000 claims description 25
• 230000002132 lysosomal effect Effects 0.000 claims description 24
• 108010086377 HLA-A3 Antigen Proteins 0.000 claims description 23
• 102000011931 Nucleoproteins Human genes 0.000 claims description 23
• 108010061100 Nucleoproteins Proteins 0.000 claims description 23
• 230000001086 cytosolic effect Effects 0.000 claims description 21
• 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 20
• 108010013476 HLA-A24 Antigen Proteins 0.000 claims description 19
• 108010091938 HLA-B7 Antigen Proteins 0.000 claims description 18
• 108091054437 MHC class I family Proteins 0.000 claims description 18
• 102000043129 MHC class I family Human genes 0.000 claims description 16
• 108010035452 HLA-A1 Antigen Proteins 0.000 claims description 15
• 101710102873 Polymerase basic protein 2 Proteins 0.000 claims description 15
• 241000282898 Sus scrofa Species 0.000 claims description 15
• 108010093013 HLA-DR1 Antigen Proteins 0.000 claims description 12
• 101710128560 Initiator protein NS1 Proteins 0.000 claims description 12
• 101710144127 Non-structural protein 1 Proteins 0.000 claims description 12
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 12
• 239000000277 virosome Substances 0.000 claims description 12
• 241000287828 Gallus gallus Species 0.000 claims description 11
• 101710085035 RNA-directed RNA polymerase catalytic subunit Proteins 0.000 claims description 11
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 230000001105 regulatory effect Effects 0.000 claims description 11
• 108060003393 Granulin Proteins 0.000 claims description 10
• 239000002502 liposome Substances 0.000 claims description 10
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 9
• 229960003767 alanine Drugs 0.000 claims description 9
• QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 8
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 8
• 108010014597 HLA-B44 Antigen Proteins 0.000 claims description 8
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 8
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 8
• 229960000187 tissue plasminogen activator Drugs 0.000 claims description 8
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 7
• 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 claims description 7
• 101710116782 Lysosome-associated membrane glycoprotein 1 Proteins 0.000 claims description 7
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 6
• 108010064885 HLA-DR3 Antigen Proteins 0.000 claims description 6
• 102000004877 Insulin Human genes 0.000 claims description 6
• 108090001061 Insulin Proteins 0.000 claims description 6
• 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 claims description 6
• 101710116771 Lysosome-associated membrane glycoprotein 2 Proteins 0.000 claims description 6
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
• 229940125396 insulin Drugs 0.000 claims description 6
• 150000002632 lipids Chemical class 0.000 claims description 6
• 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 claims description 5
• 101710166261 B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims description 5
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
• 235000004279 alanine Nutrition 0.000 claims description 5
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 4
• 229910052799 carbon Inorganic materials 0.000 claims description 4
• 230000002434 immunopotentiative effect Effects 0.000 claims description 4
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
• BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 claims description 2
• 101710199771 Matrix protein 1 Proteins 0.000 claims description 2
• 101710199769 Matrix protein 2 Proteins 0.000 claims description 2
• 229910052717 sulfur Inorganic materials 0.000 claims description 2
• 101000739160 Homo sapiens Secretoglobin family 3A member 1 Proteins 0.000 claims 1
• 102100037268 Secretoglobin family 3A member 1 Human genes 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 229960005486 vaccine Drugs 0.000 abstract description 107
• 210000001744 T-lymphocyte Anatomy 0.000 abstract description 24
• 230000009385 viral infection Effects 0.000 abstract description 13
• 230000007246 mechanism Effects 0.000 abstract description 11
• 239000008194 pharmaceutical composition Substances 0.000 abstract description 10
• 230000002265 prevention Effects 0.000 abstract description 4
• 238000011282 treatment Methods 0.000 abstract description 4
• 230000004044 response Effects 0.000 description 95
• 241000700605 Viruses Species 0.000 description 88
• 239000012634 fragment Substances 0.000 description 59
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 48
• 208000015181 infectious disease Diseases 0.000 description 48
• 230000005847 immunogenicity Effects 0.000 description 45
• 238000003556 assay Methods 0.000 description 44
• 238000011830 transgenic mouse model Methods 0.000 description 44
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 41
• 241000699660 Mus musculus Species 0.000 description 41
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 41
• 125000003275 alpha amino acid group Chemical group 0.000 description 40
• 230000003612 virological effect Effects 0.000 description 39
• 241000699670 Mus sp. Species 0.000 description 33
• 108020004414 DNA Proteins 0.000 description 32
• 241000282412 Homo Species 0.000 description 31
• 230000002163 immunogen Effects 0.000 description 31
• 238000004458 analytical method Methods 0.000 description 30
• 238000001727 in vivo Methods 0.000 description 30
• 210000001519 tissue Anatomy 0.000 description 30
• 230000000890 antigenic effect Effects 0.000 description 29
• 230000002829 reductive effect Effects 0.000 description 29
• 125000006850 spacer group Chemical group 0.000 description 29
• 239000013612 plasmid Substances 0.000 description 27
• 230000036039 immunity Effects 0.000 description 26
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
• 230000002458 infectious effect Effects 0.000 description 25
• 230000014509 gene expression Effects 0.000 description 24
• 241001465754 Metazoa Species 0.000 description 23
• 230000006870 function Effects 0.000 description 22
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 21
• 241000699666 Mus <mouse, genus> Species 0.000 description 20
• 201000010099 disease Diseases 0.000 description 20
• 230000003053 immunization Effects 0.000 description 20
• 230000037361 pathway Effects 0.000 description 20
• 108700028369 Alleles Proteins 0.000 description 19
• 108010058597 HLA-DR Antigens Proteins 0.000 description 19
• 102000006354 HLA-DR Antigens Human genes 0.000 description 19
• 108091008874 T cell receptors Proteins 0.000 description 19
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 19
• 238000002649 immunization Methods 0.000 description 19
• 239000002245 particle Substances 0.000 description 19
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 18
• 238000012360 testing method Methods 0.000 description 18
• 241000271566 Aves Species 0.000 description 17
• 125000000539 amino acid group Chemical group 0.000 description 17
• 241001529936 Murinae Species 0.000 description 16
• 238000013459 approach Methods 0.000 description 16
• 230000000694 effects Effects 0.000 description 16
• 238000000338 in vitro Methods 0.000 description 16
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 15
• 238000011161 development Methods 0.000 description 15
• 230000018109 developmental process Effects 0.000 description 15
• 238000002474 experimental method Methods 0.000 description 15
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 14
• 238000005516 engineering process Methods 0.000 description 14
• 230000001965 increasing effect Effects 0.000 description 14
• 239000000463 material Substances 0.000 description 14
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
• 241000700721 Hepatitis B virus Species 0.000 description 13
• 241000725303 Human immunodeficiency virus Species 0.000 description 13
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 13
• 239000000047 product Substances 0.000 description 13
• 238000002965 ELISA Methods 0.000 description 12
• 210000003719 b-lymphocyte Anatomy 0.000 description 12
• 230000037452 priming Effects 0.000 description 12
• 238000001890 transfection Methods 0.000 description 12
• 108091026890 Coding region Proteins 0.000 description 11
• 238000011510 Elispot assay Methods 0.000 description 11
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 11
• 229940124873 Influenza virus vaccine Drugs 0.000 description 11
• 108091028043 Nucleic acid sequence Proteins 0.000 description 11
• 230000008901 benefit Effects 0.000 description 11
• 238000009396 hybridization Methods 0.000 description 11
• 239000013642 negative control Substances 0.000 description 11
• 238000013518 transcription Methods 0.000 description 11
• 230000035897 transcription Effects 0.000 description 11
• 238000002255 vaccination Methods 0.000 description 11
• 239000013603 viral vector Substances 0.000 description 11
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
• 241000712431 Influenza A virus Species 0.000 description 10
• 210000000612 antigen-presenting cell Anatomy 0.000 description 10
• 150000001875 compounds Chemical class 0.000 description 10
• 230000006698 induction Effects 0.000 description 10
• 108020004999 messenger RNA Proteins 0.000 description 10
• 238000000159 protein binding assay Methods 0.000 description 10
• 101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 9
• 102100038823 RNA-binding protein 45 Human genes 0.000 description 9
• 238000004422 calculation algorithm Methods 0.000 description 9
• 235000013330 chicken meat Nutrition 0.000 description 9
• 210000005260 human cell Anatomy 0.000 description 9
• 230000008569 process Effects 0.000 description 9
• 241000272517 Anseriformes Species 0.000 description 8
• 101710132601 Capsid protein Proteins 0.000 description 8
• 230000005867 T cell response Effects 0.000 description 8
• 239000002671 adjuvant Substances 0.000 description 8
• 230000034994 death Effects 0.000 description 8
• 231100000517 death Toxicity 0.000 description 8
• 238000013461 design Methods 0.000 description 8
• 238000009472 formulation Methods 0.000 description 8
• 230000002068 genetic effect Effects 0.000 description 8
• 229960003971 influenza vaccine Drugs 0.000 description 8
• 210000003712 lysosome Anatomy 0.000 description 8
• 230000001868 lysosomic effect Effects 0.000 description 8
• 238000005457 optimization Methods 0.000 description 8
• 230000001681 protective effect Effects 0.000 description 8
• 230000001225 therapeutic effect Effects 0.000 description 8
• 108010036972 HLA-A11 Antigen Proteins 0.000 description 7
• 241000124008 Mammalia Species 0.000 description 7
• 108020004511 Recombinant DNA Proteins 0.000 description 7
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 7
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
• 230000000875 corresponding effect Effects 0.000 description 7
• 230000002209 hydrophobic effect Effects 0.000 description 7
• 210000000987 immune system Anatomy 0.000 description 7
• 238000011065 in-situ storage Methods 0.000 description 7
• 108700010900 influenza virus proteins Proteins 0.000 description 7
• 230000000670 limiting effect Effects 0.000 description 7
• 210000004379 membrane Anatomy 0.000 description 7
• 239000012528 membrane Substances 0.000 description 7
• 230000001717 pathogenic effect Effects 0.000 description 7
• 208000024891 symptom Diseases 0.000 description 7
• 230000009261 transgenic effect Effects 0.000 description 7
• 230000032258 transport Effects 0.000 description 7
• 101710158312 DNA-binding protein HU-beta Proteins 0.000 description 6
• 241000283086 Equidae Species 0.000 description 6
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 6
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 6
• 108091034117 Oligonucleotide Proteins 0.000 description 6
• 241000286209 Phasianidae Species 0.000 description 6
• 230000009260 cross reactivity Effects 0.000 description 6
• 210000000265 leukocyte Anatomy 0.000 description 6
• 230000035772 mutation Effects 0.000 description 6
• 239000002773 nucleotide Substances 0.000 description 6
• 125000003729 nucleotide group Chemical group 0.000 description 6
• 238000003752 polymerase chain reaction Methods 0.000 description 6
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 6
• 230000003248 secreting effect Effects 0.000 description 6
• 230000035945 sensitivity Effects 0.000 description 6
• 230000004936 stimulating effect Effects 0.000 description 6
• 238000006467 substitution reaction Methods 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 108010041986 DNA Vaccines Proteins 0.000 description 5
• 229940021995 DNA vaccine Drugs 0.000 description 5
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 5
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 5
• 108010039918 Polylysine Proteins 0.000 description 5
• 241000282887 Suidae Species 0.000 description 5
• 108010067390 Viral Proteins Proteins 0.000 description 5
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
• 238000010171 animal model Methods 0.000 description 5
• 230000005875 antibody response Effects 0.000 description 5
• 239000011230 binding agent Substances 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 210000004899 c-terminal region Anatomy 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 238000004590 computer program Methods 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 235000013601 eggs Nutrition 0.000 description 5
• 230000002121 endocytic effect Effects 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 230000002708 enhancing effect Effects 0.000 description 5
• 208000037797 influenza A Diseases 0.000 description 5
• 210000004185 liver Anatomy 0.000 description 5
• 108010045758 lysosomal proteins Proteins 0.000 description 5
• 210000003205 muscle Anatomy 0.000 description 5
• 229910052757 nitrogen Inorganic materials 0.000 description 5
• 229920000656 polylysine Polymers 0.000 description 5
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
• 210000003079 salivary gland Anatomy 0.000 description 5
• 230000028327 secretion Effects 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 210000004988 splenocyte Anatomy 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 230000029812 viral genome replication Effects 0.000 description 5
• 210000002845 virion Anatomy 0.000 description 5
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 4
• 241000282693 Cercopithecidae Species 0.000 description 4
• 101710094648 Coat protein Proteins 0.000 description 4
• 241000701022 Cytomegalovirus Species 0.000 description 4
• 239000004471 Glycine Substances 0.000 description 4
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 4
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 4
• 101710125418 Major capsid protein Proteins 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 101710141454 Nucleoprotein Proteins 0.000 description 4
• 101710083689 Probable capsid protein Proteins 0.000 description 4
• 230000002238 attenuated effect Effects 0.000 description 4
• 230000005540 biological transmission Effects 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 239000012636 effector Substances 0.000 description 4
• 102000054766 genetic haplotypes Human genes 0.000 description 4
• 230000036541 health Effects 0.000 description 4
• 230000002998 immunogenetic effect Effects 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 210000004072 lung Anatomy 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 230000003472 neutralizing effect Effects 0.000 description 4
• 229940023146 nucleic acid vaccine Drugs 0.000 description 4
• 230000008520 organization Effects 0.000 description 4
• 210000005259 peripheral blood Anatomy 0.000 description 4
• 239000011886 peripheral blood Substances 0.000 description 4
• 239000000546 pharmaceutical excipient Substances 0.000 description 4
• 239000012071 phase Substances 0.000 description 4
• 150000003904 phospholipids Chemical class 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 239000003981 vehicle Substances 0.000 description 4
• 229960004854 viral vaccine Drugs 0.000 description 4
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
• 241000972773 Aulopiformes Species 0.000 description 3
• 241000272161 Charadriiformes Species 0.000 description 3
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000767151 Homo sapiens General vesicular transport factor p115 Proteins 0.000 description 3
• 101001093919 Homo sapiens SEC14-like protein 2 Proteins 0.000 description 3
• 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 description 3
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
• 241000282553 Macaca Species 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 241000282579 Pan Species 0.000 description 3
• 241000223960 Plasmodium falciparum Species 0.000 description 3
• 229920001213 Polysorbate 20 Polymers 0.000 description 3
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
• 238000012300 Sequence Analysis Methods 0.000 description 3
• 101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 3
• 241000282458 Ursus sp. Species 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• 125000003118 aryl group Chemical group 0.000 description 3
• 206010064097 avian influenza Diseases 0.000 description 3
• 230000001580 bacterial effect Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 125000002091 cationic group Chemical group 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 239000011651 chromium Substances 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 230000001276 controlling effect Effects 0.000 description 3
• 229940028617 conventional vaccine Drugs 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 210000003527 eukaryotic cell Anatomy 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 229910052739 hydrogen Inorganic materials 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 229910052740 iodine Inorganic materials 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 239000011325 microbead Substances 0.000 description 3
• 238000010369 molecular cloning Methods 0.000 description 3
• 238000010172 mouse model Methods 0.000 description 3
• 238000006386 neutralization reaction Methods 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
• 239000013641 positive control Substances 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 238000009021 pre-vaccination Methods 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 229940023143 protein vaccine Drugs 0.000 description 3
• 230000003362 replicative effect Effects 0.000 description 3
• 235000019515 salmon Nutrition 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 238000010845 search algorithm Methods 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 210000003491 skin Anatomy 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 230000000699 topical effect Effects 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 229940125575 vaccine candidate Drugs 0.000 description 3
• 229910052720 vanadium Inorganic materials 0.000 description 3
• 229910052727 yttrium Inorganic materials 0.000 description 3
• DPISVYSMNIFXGB-UHFFFAOYSA-N 2-(9h-carbazol-3-yl)ethanamine Chemical compound C1=CC=C2C3=CC(CCN)=CC=C3NC2=C1 DPISVYSMNIFXGB-UHFFFAOYSA-N 0.000 description 2
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 241000282421 Canidae Species 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 241000282668 Cebus Species 0.000 description 2
• 241000282551 Cercopithecus Species 0.000 description 2
• 241000282994 Cervidae Species 0.000 description 2
• 241000283153 Cetacea Species 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 208000035473 Communicable disease Diseases 0.000 description 2
• 206010011224 Cough Diseases 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 241000702421 Dependoparvovirus Species 0.000 description 2
• 241000283074 Equus asinus Species 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 229920001917 Ficoll Polymers 0.000 description 2
• 241000282818 Giraffidae Species 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102000001398 Granzyme Human genes 0.000 description 2
• 108060005986 Granzyme Proteins 0.000 description 2
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 2
• 108010075704 HLA-A Antigens Proteins 0.000 description 2
• 102000011786 HLA-A Antigens Human genes 0.000 description 2
• 108010058607 HLA-B Antigens Proteins 0.000 description 2
• 108010046732 HLA-DR4 Antigen Proteins 0.000 description 2
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 2
• 241001272567 Hominoidea Species 0.000 description 2
• 241000282596 Hylobatidae Species 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 102000004388 Interleukin-4 Human genes 0.000 description 2
• 108090000978 Interleukin-4 Proteins 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
• 241000721578 Melopsittacus Species 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 241000282339 Mustela Species 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 241000282320 Panthera leo Species 0.000 description 2
• 241000282376 Panthera tigris Species 0.000 description 2
• 241000282520 Papio Species 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 108091093037 Peptide nucleic acid Proteins 0.000 description 2
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 2
• 241000283216 Phocidae Species 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 241000282405 Pongo abelii Species 0.000 description 2
• 241001415846 Procellariidae Species 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• 241000555745 Sciuridae Species 0.000 description 2
• 101710172711 Structural protein Proteins 0.000 description 2
• 238000000692 Student's t-test Methods 0.000 description 2
• 241000287182 Sturnidae Species 0.000 description 2
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 230000006978 adaptation Effects 0.000 description 2
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
• 229940037003 alum Drugs 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 210000000988 bone and bone Anatomy 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 230000036755 cellular response Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 229910052804 chromium Inorganic materials 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 108091036078 conserved sequence Proteins 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 230000002596 correlated effect Effects 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 230000002939 deleterious effect Effects 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 239000012645 endogenous antigen Substances 0.000 description 2
• 210000002615 epidermis Anatomy 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• 210000000887 face Anatomy 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 230000007614 genetic variation Effects 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 230000028996 humoral immune response Effects 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 239000012678 infectious agent Substances 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 230000000968 intestinal effect Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• 238000011005 laboratory method Methods 0.000 description 2
• 239000010410 layer Substances 0.000 description 2
• 231100000518 lethal Toxicity 0.000 description 2
• 230000001665 lethal effect Effects 0.000 description 2
• 238000007834 ligase chain reaction Methods 0.000 description 2
• 239000003287 lymphocyte surface marker Substances 0.000 description 2
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 210000004400 mucous membrane Anatomy 0.000 description 2
• 210000004165 myocardium Anatomy 0.000 description 2
• 230000010807 negative regulation of binding Effects 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 238000002515 oligonucleotide synthesis Methods 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 229940023041 peptide vaccine Drugs 0.000 description 2
• 229930192851 perforin Natural products 0.000 description 2
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 244000144977 poultry Species 0.000 description 2
• 235000013594 poultry meat Nutrition 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 229940023867 prime-boost vaccine Drugs 0.000 description 2
• 239000013615 primer Substances 0.000 description 2
• 229940021993 prophylactic vaccine Drugs 0.000 description 2
• 230000017854 proteolysis Effects 0.000 description 2
• 230000002797 proteolythic effect Effects 0.000 description 2
• 230000005180 public health Effects 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000005945 translocation Effects 0.000 description 2
• 238000009966 trimming Methods 0.000 description 2
• 229910052721 tungsten Inorganic materials 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• OIXLLKLZKCBCPS-RZVRUWJTSA-N (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CCCNC(N)=N OIXLLKLZKCBCPS-RZVRUWJTSA-N 0.000 description 1
• SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 1
• TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
• WALUVDCNGPQPOD-UHFFFAOYSA-M 2,3-di(tetradecoxy)propyl-(2-hydroxyethyl)-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCOCC(C[N+](C)(C)CCO)OCCCCCCCCCCCCCC WALUVDCNGPQPOD-UHFFFAOYSA-M 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• YVOOPGWEIRIUOX-UHFFFAOYSA-N 2-azanyl-3-sulfanyl-propanoic acid Chemical compound SCC(N)C(O)=O.SCC(N)C(O)=O YVOOPGWEIRIUOX-UHFFFAOYSA-N 0.000 description 1
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
• OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 108091008875 B cell receptors Proteins 0.000 description 1
• 208000003950 B-cell lymphoma Diseases 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 108010075254 C-Peptide Proteins 0.000 description 1
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
• 108091008048 CMVpp65 Proteins 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 102400001321 Cathepsin L Human genes 0.000 description 1
• 108090000624 Cathepsin L Proteins 0.000 description 1
• 108090000613 Cathepsin S Proteins 0.000 description 1
• 102100035654 Cathepsin S Human genes 0.000 description 1
• 108010084457 Cathepsins Proteins 0.000 description 1
• 102000005600 Cathepsins Human genes 0.000 description 1
• 231100000023 Cell-mediated cytotoxicity Toxicity 0.000 description 1
• 206010057250 Cell-mediated cytotoxicity Diseases 0.000 description 1
• 229940123150 Chelating agent Drugs 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 241000557626 Corvus corax Species 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• XULFJDKZVHTRLG-JDVCJPALSA-N DOSPA trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F.CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)CCNC(=O)C(CCCNCCCN)NCCCN)OCCCCCCCC\C=C/CCCCCCCC XULFJDKZVHTRLG-JDVCJPALSA-N 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 108010016626 Dipeptides Proteins 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 102000005593 Endopeptidases Human genes 0.000 description 1
• 108010059378 Endopeptidases Proteins 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 102000018389 Exopeptidases Human genes 0.000 description 1
• 108010091443 Exopeptidases Proteins 0.000 description 1
• 208000000666 Fowlpox Diseases 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 241000696272 Gull adenovirus Species 0.000 description 1
• 241000197306 H1N1 subtype Species 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 108010088729 HLA-A*02:01 antigen Proteins 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 102000006947 Histones Human genes 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 238000012404 In vitro experiment Methods 0.000 description 1
• 241000713297 Influenza C virus Species 0.000 description 1
• 208000002979 Influenza in Birds Diseases 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• 150000008575 L-amino acids Chemical class 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 241000272168 Laridae Species 0.000 description 1
• 108010028921 Lipopeptides Proteins 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 241000282560 Macaca mulatta Species 0.000 description 1
• 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 241000711408 Murine respirovirus Species 0.000 description 1
• 208000000112 Myalgia Diseases 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 101710118538 Protease Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
• 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 230000037453 T cell priming Effects 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 238000005076 Van der Waals potential Methods 0.000 description 1
• 206010058874 Viraemia Diseases 0.000 description 1
• 108700005077 Viral Genes Proteins 0.000 description 1
• 108010065667 Viral Matrix Proteins Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 108700002693 Viral Replicase Complex Proteins Proteins 0.000 description 1
• 208000035472 Zoonoses Diseases 0.000 description 1
• UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 description 1
• HIHOWBSBBDRPDW-PTHRTHQKSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate Chemical compound C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HIHOWBSBBDRPDW-PTHRTHQKSA-N 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 230000002776 aggregation Effects 0.000 description 1
• 238000004220 aggregation Methods 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 230000027645 antigenic variation Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 210000000576 arachnoid Anatomy 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 239000012752 auxiliary agent Substances 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 108010006025 bovine growth hormone Proteins 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 210000001736 capillary Anatomy 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 210000005242 cardiac chamber Anatomy 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 239000013553 cell monolayer Substances 0.000 description 1
• 230000005859 cell recognition Effects 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 230000005890 cell-mediated cytotoxicity Effects 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 238000012411 cloning technique Methods 0.000 description 1
• 238000000975 co-precipitation Methods 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 230000001461 cytolytic effect Effects 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• 210000004395 cytoplasmic granule Anatomy 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 238000009795 derivation Methods 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 239000007933 dermal patch Substances 0.000 description 1
• 210000004207 dermis Anatomy 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 230000006334 disulfide bridging Effects 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 210000003162 effector t lymphocyte Anatomy 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 238000005421 electrostatic potential Methods 0.000 description 1
• 210000001174 endocardium Anatomy 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 230000004907 flux Effects 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 230000005021 gait Effects 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 210000005095 gastrointestinal system Anatomy 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 210000004392 genitalia Anatomy 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 230000035931 haemagglutination Effects 0.000 description 1
• 210000002837 heart atrium Anatomy 0.000 description 1
• 210000005003 heart tissue Anatomy 0.000 description 1
• 210000001308 heart ventricle Anatomy 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 208000021760 high fever Diseases 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 102000055691 human APC Human genes 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 230000008105 immune reaction Effects 0.000 description 1
• 230000008073 immune recognition Effects 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 230000009851 immunogenic response Effects 0.000 description 1
• 238000010324 immunological assay Methods 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 208000037798 influenza B Diseases 0.000 description 1
• 208000037799 influenza C Diseases 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 229940065638 intron a Drugs 0.000 description 1
• 108010028930 invariant chain Proteins 0.000 description 1
• 239000002085 irritant Substances 0.000 description 1
• 231100000021 irritant Toxicity 0.000 description 1
• 230000000622 irritating effect Effects 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
• 231100000636 lethal dose Toxicity 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 210000005228 liver tissue Anatomy 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 201000006512 mast cell neoplasm Diseases 0.000 description 1
• 208000006971 mastocytoma Diseases 0.000 description 1
• 210000003071 memory t lymphocyte Anatomy 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• 229940022007 naked DNA vaccine Drugs 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 229940100661 nasal inhalant Drugs 0.000 description 1
• 229940097496 nasal spray Drugs 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 230000030648 nucleus localization Effects 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 210000004923 pancreatic tissue Anatomy 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000007918 pathogenicity Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 210000003516 pericardium Anatomy 0.000 description 1
• 210000003200 peritoneal cavity Anatomy 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 108010011110 polyarginine Proteins 0.000 description 1
• 210000004896 polypeptide structure Anatomy 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 230000003334 potential effect Effects 0.000 description 1
• 238000012910 preclinical development Methods 0.000 description 1
• 238000002810 primary assay Methods 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000001915 proofreading effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 235000004252 protein component Nutrition 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 235000021251 pulses Nutrition 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 210000005084 renal tissue Anatomy 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 229920002477 rna polymer Polymers 0.000 description 1
• 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
• 238000003118 sandwich ELISA Methods 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000001932 seasonal effect Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 239000002884 skin cream Substances 0.000 description 1
• 206010041232 sneezing Diseases 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 210000002330 subarachnoid space Anatomy 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000002381 testicular Effects 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 229940021747 therapeutic vaccine Drugs 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 229940041677 topical spray Drugs 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 238000002627 tracheal intubation Methods 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 230000001810 trypsinlike Effects 0.000 description 1
• 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 239000002691 unilamellar liposome Substances 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 210000000605 viral structure Anatomy 0.000 description 1
• 239000000304 virulence factor Substances 0.000 description 1
• 230000007923 virulence factor Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1
• 206010048282 zoonosis Diseases 0.000 description 1